European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Patient Perception of Symptom Variability. A Cross-sectional Study of Patients With Severe COPD.
Sponsor: AstraZeneca
Listed as NCT00722267, this observational or N/A phase trial focuses on Chronic Obstructive Pulmonary Disease (COPD) and remains completed. Sponsored by AstraZeneca, it has been updated 9 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 4 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jul 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
's-Hertogenbosch, Netherlands , A Coruña, Spain , Aalborg, Denmark , Aalst, Belgium , Aarhus, Denmark , Adana, Turkey (Türkiye) , Agde, France , Aix-en-Provence, France , Akyokus-Konya, Turkey (Türkiye) , Alamagro, Spain and 596 more locations